Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - CASH & EQUIVALENTS
Cash & Equivalents DNLI - Denali Therapeutics Inc.
127 M
LAST VALUE
-34.19%
2 YEAR CAGR
10.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR